Form 4: H.B. Fuller Exec Exercises Options, Sells Shares
Insider Transaction Report
H.B. Fuller's Executive VP, Nathan D. Weaver, exercised stock options and subsequently sold a portion of the acquired shares for diversification.
Summary
- Nathan D. Weaver, Executive VP, Business Transformation at H.B. Fuller Co. (FUL), exercised 9,546 employee stock options on November 13, 2025, at a strike price of $33.38 per share.
- Concurrently, Mr. Weaver sold 7,075 shares of H.B. Fuller common stock on November 13, 2025, at a weighted average price of $58.3771 per share, with prices ranging from $58.02 to $58.6850.
- Following these transactions, Mr. Weaver directly beneficially owns 9,441 shares of common stock, which includes shares acquired through a dividend reinvestment plan.
- Mr. Weaver retains significant derivative holdings, including various employee stock options, 5,895.44 phantom units, and 4,332.62 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral. The transaction is a routine insider exercise and sale, which is common for executive compensation and personal financial planning. While selling shares can sometimes be viewed negatively, the exercise price being significantly lower than the sale price indicates a positive gain for the executive and reflects a higher stock price for the company.
Positives
- The executive monetized vested options at a price significantly higher than the exercise price, indicating a gain for the insider.
- The sale price of $58.3771 is substantially above the option exercise price of $33.38, reflecting positive stock performance for the company.
Negatives
- An executive selling shares could be perceived negatively by some investors, potentially signaling a lack of confidence, although it is often for personal financial planning or diversification.
Future Outlook
NA
Industry Context
This filing represents a routine insider transaction for an executive at H.B. Fuller Co., a global specialty chemicals company. Such transactions are common for executives managing their personal equity holdings and do not inherently reflect broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders may interpret the executive's sale as a signal, though it is often for personal diversification or tax purposes rather than a reflection of company performance. The transaction itself does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 01/19/2017 | Vesting date for 9,546 employee stock options (100% vested) that were exercised. |
| 01/26/2018 | Vesting date for 4,976 employee stock options (100% vested). |
| 01/25/2019 | Vesting date for 4,585 employee stock options (100% vested). |
| 01/24/2020 | Vesting date for 6,115 employee stock options (100% vested). |
| 01/24/2021 | Vesting date for 5,362 employee stock options (100% vested). |
| 04/02/2021 | Vesting date for 9,732 employee stock options (100% vested). |
| 01/27/2022 | Vesting date for 11,992 employee stock options (100% vested). |
| 01/24/2023 | Vesting date for 8,249 employee stock options (100% vested). |
| 01/24/2024 | First annual installment vesting date for 9,634 employee stock options and 562.91 Restricted Stock Units. |
| 01/26/2025 | First annual installment vesting date for 9,806 employee stock options and 1,129.28 Restricted Stock Units. |
| 11/13/2025 | Date of employee stock option exercise and subsequent sale of common stock. |
| 01/19/2026 | Expiration date for the 9,546 employee stock options that were exercised. |
| 01/27/2026 | First annual installment vesting date for 14,844 employee stock options and 2,640.43 Restricted Stock Units. |
| 01/26/2027 | Expiration date for 4,976 employee stock options and 1,129.28 Restricted Stock Units. |
| 01/27/2028 | Expiration date for 2,640.43 Restricted Stock Units. |
| 01/25/2028 | Expiration date for 4,585 employee stock options. |
| 01/24/2029 | Expiration date for 6,115 employee stock options. |
| 01/24/2030 | Expiration date for 5,362 employee stock options. |
| 04/02/2030 | Expiration date for 9,732 employee stock options. |
| 01/27/2031 | Expiration date for 11,992 employee stock options. |
| 01/24/2032 | Expiration date for 8,249 employee stock options. |
| 01/24/2033 | Expiration date for 9,634 employee stock options. |
| 01/26/2034 | Expiration date for 9,806 employee stock options. |
| 01/27/2035 | Expiration date for 14,844 employee stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction where an executive exercised stock options and sold a portion of the shares. While the sale itself might be viewed with slight caution, the significant gain realized by the executive (sale price well above exercise price) indicates positive stock performance for H.B. Fuller. However, a single insider transaction, especially a partial sale following an option exercise, is generally not sufficient to alter a fundamental investment thesis. Investors should consider this in the broader context of the company's financial performance, strategic outlook, and overall market conditions. Therefore, a 'hold' recommendation is appropriate as this specific filing does not provide new information warranting a change in investment stance.
Keywords
H.B. Fuller, FUL, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, Nathan D. Weaver, Equity Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.